Conference Coverage

Bladder cancer: Two chemoradiation therapy regimens on par for muscle-invasive disease

Publish date: February 10, 2018

 

AT THE GENITOURINARY CANCERS SYMPOSIUM

SOURCE: Coen, J. et al, 2018 Genitourinary Cancers Symposium, Abstract 408

Pages

Recommended Reading

Prostate cancer’s future seen in molecular tests
MDedge Surgery
Prostate cancer’s future seen in molecular tests
MDedge Surgery
10-year follow-up: Localized prostate cancer treatments offer similar efficacy
MDedge Surgery
Adjuvant chemo prolonged survival after radical nephroureterectomy
MDedge Surgery
ASCO offers practice guidance on small renal masses
MDedge Surgery
RNA-based biopsy test bests NCCN risk stratification for PC prognosis
MDedge Surgery
Is pain or dependency driving elevated opioid use among long-term cancer survivors?
MDedge Surgery
Robot-assisted prostatectomy providing better outcomes
MDedge Surgery
Perioperative blood transfusion linked to worse outcomes in renal cell carcinoma
MDedge Surgery
Adjuvant chemo halves DFS events in upper-tract urothelial cancer
MDedge Surgery